Prevention Services Evaluation Partnerships: Building Evidence for Mental Health, Substance Use, In-home Parent Skill-based, and Kinship Navigator Programs and Services (Current Closing Date for Applications: Jul 11)
Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults
Policy Research Programme – (36-01-01) – Collaborative risk assessment and management planning across the forensic mental health pathway in England (Submission deadline for applications is 1PM on 11 July)
Alcohol Treatment and Recovery Research (R34 Clinical Trial required) (Letter of intent due date: June 17)
OJJDP FY 2023 Center for Reducing Racial and Ethnic Disparities (R/ED) in Juvenile Justice (Grants.gov deadline: 7/11)
£2.5m Grant awarded to establish a West Midlands Evidence Synthesis Group (ESG) to provide best evidence for health and social care
Notice of Special Interest (NOSI): Alzheimer’s-Focused Administrative Supplements for NIH Grants not Focused on Alzheimer’s Disease (First available due date: Oct 02
MRFF – Dementia, Ageing and Aged Care Mission – 2023 Dementia, Ageing and Aged Care Grant Opportunity (Minimum data due date: 2 August
Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) (Letter of intent due date: June 17)
Notice of Special Interest (NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health Disparities (Expiration date: June 06, 2026
Innovations in Measuring Community Perceptions Challenge (Webinar on June 6) (Submission period ends: July 31)
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) (Letter of Intent due 30 days prior to the application due date)
Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01 Clinical Trial Required) (Letter of Intent due 30 days prior to the application due date)
Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required)
Social work students and apprentices: submit your best argument for this year’s question for the chance to win one of four grants of £500.
Social work students and apprentices: submit your best argument for this year’s question for the chance to win one of four grants of £500 (Closes 23 June)
RfPB Under-represented disciplines and specialisms highlight notice: Methodologists (Expression of interest due by 16 August)
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) (Letter of Intent due 30 days prior to the application due date)
Cooperative Agreements for 988 Suicide and Crisis Lifeline Crisis Center Follow-Up Programs (Due by June 26)
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 – Clinical Trial Optional)
Children and Youth Resilience Challenge: Innovative, community-led solutions to advance the mental health of children and youth (Phase 1 open until 07/07)
Pilot Studies to Test the Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34 Clinical Trial Required) (Letter of Intent due 30 days prior to the application due date)
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) (Letter of Intent Due 30 days prior to the application due date)
Biden-Harris Administration Announces Nearly $100 Million in Continued Support for Mental Health and Student Wellness Through Bipartisan Safer Communities Act
Notice of Special Interest (NOSI): The HIV-HCV-Substance Use Disorder Syndemic: Therapeutic Approaches (Expiration Date: Sept 8)
HHS Announces Over $65 Million to Address the Maternal Health Crisis and Invest in New Approaches to Care
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) (Letter of Intent Due 30 days prior to the application due date)
Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed) (Letter of intent due date: Sept 23)
Request for Applications (RFA): Revision Applications to Support Research on Prevention and Cessation of Menthol Cigarette Use in Populations that Experience Health Disparities (R01, Clinical Trial Optional) (Open Date (Earliest submission date: May 19
Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) (Letter of Intent Due 30 days prior to the Application Due date)
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required) (Letter of Intent due 30 days prior to the application due date)
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) (
Virginia Commonwealth University School of Social Work: Postdoctoral Fellowship in Research on Social Determinants of Health & Prevention Sciences